Acta Med. 2005, 48: 75-80
https://doi.org/10.14712/18059694.2018.35
The Diagnostic Role of Urinary N-Acetyl-β-D-glucosaminidase (NAG) Activity in the Detection of Renal Tubular Impairment
References
1. S, El-Hefnawy H, El-Yamani MY, Azmi Y. Urinary N-acetyl-beta- D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy. East Mediterr Health J 2002; 8:24–30.
2. M, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS. Urinary Nacetyl- beta-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. The Bogalusa heart study. Am J Hypertens 1996; 9:157–61.
<https://doi.org/10.1016/0895-7061(95)00336-3>
3. PS, Niemi T, Lindgren L, Lepantalo M. Endovascular vs open AAA repair: similar effects on renal proximal tubular function. Scand J Surg 2004; 93:52–6.
<https://doi.org/10.1177/145749690409300111>
4. S, Caliskan S, Kasapcopur O. Tubular functions in familial Mediterranean fever. Turk J Pediatr 2002; 44:317–20.
5. S, Yildizas D, Anarat A, Burgut HR. Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol 2001; 16:256–9.
<https://doi.org/10.1007/s004670000535>
6. T, Soichiro O, Kasahara T, Uchiyama M. Asymptomatic primary hyper-Nacetyl- beta-D-glucosaminidaseuria: a new clinical entity? Pediatr Nephrol 2002; 17:560–5.
<https://doi.org/10.1007/s00467-002-0920-4>
7. S, Akil I, Akil T et al. Renal resistive indexes and some renal functions in liver cirrhotic children. Pediatr Int 2004; 46:67–71.
<https://doi.org/10.1111/j.1442-200X.2004.01826.x>
8. AA, Salah AM, Abdolmotaal E et al. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis. World J Urol 1998; 16:413–6.
<https://doi.org/10.1007/s003450050093>
9. E, Olah AV, Bartyik K et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 2004; 43:668–73.
<https://doi.org/10.1002/pbc.20143>
10. A, Scarlecio F, Martino F et al. Evaluation of N-acetyl-beta-D-glucosaminidase in upper and lower urinary tract infections in childhood. Clinical study of 168 children. Minerva Pediatr 1996; 48:503–7.
11. S, Hacibekiroglu M, Sever I, Ozbay G, Arisoy N. Urinary N-acetyl-beta- D-glucosaminidase and beta-2–microglobulin excretion in primary nephrotic children. Nephron 1996; 74:401–4.
12. S, Ficicioglu C, Hacibekiroglu M et al. Tubular markers in children with insulin dependent diabetes mellitus. Turk J Pediatr 1997; 39:213–8.
13. MC, Peters CA, Retik AB, Mandell J. Urinary levels of the renal tubular enzyme N-acetyl-beta-D-glucosaminidase in unilateral obstructive uropathy. J Urol 1994; 151:442–5.
<https://doi.org/10.1016/S0022-5347(17)34983-2>
14. KS, Jeyaratnam J, Lee J et al. Lead-induced nephropathy: relationship between various biological exposure indices and early markers of nephrotoxicity. Am J Ind Med 1995; 27:883–95.
<https://doi.org/10.1002/ajim.4700270612>
15. JSP. Models used to assess renal function. Drug Devel Res 1994; 32:247–55.
<https://doi.org/10.1002/ddr.430320409>
16. L, Olah AV, Pocsi I, Varga J, Balla G, Price RG. Age-dependent urinary N-acetyl-beta-D-glucosaminidase activity in healthy children. Orv Hetil 1994; 135:1301–3.
17. L, Pócsi I. Urinary N-Acetyl-β-D-glucosaminidase determination in newborns and children: methods and diagnostic applications. Eur J Clin Chem Clin Bioch 1995; 33:575–87.
18. L, Olah AV, Clemens B, Gyorgy I, Varga J. Urinary N-acetyl-beta-D-glucosaminidase in epileptic children treated with antiepileptic drugs. Arch Dis Child 2000; 83:420–2.
<https://doi.org/10.1136/adc.83.5.420>
<PubMed>
19. SC, Taylor GM, Shah V. Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome. Pediatr Nephrol 1998; 12:643–7.
<https://doi.org/10.1007/s004670050519>
20. WB, Tang ZH, Chen HY et al. Change in the level of inflammatory cytokines and their relationship to the indicator in evaluating renal tubules injury of urinary in neonates with asphyxia. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003; 15:94–6.
21. IA, Afifi AM, Shouman AE, EL-Sady AK. Effects of smoking and lead exposure on proximal tubular integrity among Egyptian industrial workers. Arch Med Res 2004; 35:59–65.
<https://doi.org/10.1016/j.arcmed.2003.08.009>
22. V, Mussap M, Osio D, Pizzini C, Plebani M. Urinary excretion of N-acetyl- beta-D-glucosaminidase and epidermal gfrowth factor in paediatric patients receiving cefixime prophylaxis for recurrent urinary tract infections. Clin Drug Invest 2001; 21:511–18.
<https://doi.org/10.2165/00044011-200121070-00007>
23. C, Conti G, Chimenz R, Ricca M. N-acetyl-beta-D-glucosaminidase and beta-2–microglobulin: prognostic markers in idiopathic nephrotic syndrome. J Nephrol 1999; 12:51–5.
24. CD, Shah V, Dillon MJ. Tubular proteinuria in reflux nephropathy: post ureteric re-implanatation. Pediatr Nephrol 1996; 10:559–63.
<https://doi.org/10.1007/s004670050160>
25. L, Misselwitz J, Fleck C et al. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol 2003; 40:348–54.
<https://doi.org/10.1002/mpo.10293>
26. H, Sumita S, Wada H et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology 1998; 89:307–22.
<https://doi.org/10.1097/00000542-199808000-00006>
27. H, Adachi Y. Renal function in surgical patients after administration of low-flow sevoflurane and amikacin. J Anesth 2002; 16:17–22.
<https://doi.org/10.1007/s540-002-8089-9>
28. PH, Tsai WS, Tsai WY, Lee JS, Tsau YK, Chen CH. Urinary N-acetyl-beta- D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol 1996; 16:300–3.
<https://doi.org/10.1159/000169013>
29. Y, Kakihara T, Imai C, Tanaka A, Watanabe A, Uchiyama M. Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children. Pediatr Int 2004; 46:570–5.
<https://doi.org/10.1111/j.1442-200x.2004.01958.x>
30. BA, Rifai N, Getson P, Akram S, Majd M, Wiedermann BL. Urinary N-acetyl-beta-D-glucosaminidase and beta-2–microglobulin in the diagnosis of urinary tract infection in febrile infants. Pediatr Infect Dis J 1994; 13:294–9.
<https://doi.org/10.1097/00006454-199404000-00009>
31. K, Chiba M, Hashizume M et al. Renal tubular dysfunction in children living in the Aral Sea Region. Arch Dis Child 2003; 88:966–8.
<https://doi.org/10.1136/adc.88.11.966>
<PubMed>
32. H, Takashima T, Kishikawa H, Emura S, Ohmori K. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy. Int J Clin Pract 1997; 51:489–90.
33. S, Aydin A, Turkmen M, Akhunlar H, Fadiloglu M, Tavli V. Investigation of relationship between idiopathic hypercalciuria and urinary enzyme activities. J Assoc Physicians India 1998; 46:784–5.
34. T, Sasai-Takedatsu M, Hirata Y, Kobayashi Y. Characterization of renal tubular damage in preterm infants with renal failure. Acta Paediatr Jpn 1994; 36:392–5.
<https://doi.org/10.1111/j.1442-200X.1994.tb03208.x>
35. O, Hartman R, Muller C, Danne T, Weber B. Predictive value of tubular markers for the development of microalbuminaurie in adolescents with diabetes. Horm Res 1998; 50(Suppl 1):23–7.
36. M, Jazwinska-Tarnawska E, Hurkacz M, Orzechowska-Juzwenko K, Pilecki W, Klempous J. The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. Int J Clin Pharmacol Ther 2003; 41:281–6.
<https://doi.org/10.5414/CPP41281>
37. P, Margreiter R, Pfaller W. Reduced renal allograft survival is related to low urinary N-acetyl-beta-D-glucosaminidase excretion during the first posttransplant month. Transplantation 1996; 61:388–92.
<https://doi.org/10.1097/00007890-199602150-00011>
38. GF, Russell-Eggitt IM, van’t Hoff WG. Early proximal tubular dysfunction in Lowe’s syndrome. Arch Dis Child 2004; 89:479–80.
<https://doi.org/10.1136/adc.2003.031187>
<PubMed>
39. PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV. Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 1993; 9:705–10.
<https://doi.org/10.1007/BF00868717>
40. BG, Henning RH, Epema AH et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2004; 93:793–8.
<https://doi.org/10.1093/bja/aeh266>
41. R, Scaramuzza A, Cortona L, Valenti G, d’Annunzio G, Melzi d Éril GV. Increased urinary N-acetyl-beta-D-glucosaminidase excretion in young insulin-dependent diabetic patients. Diabetes Res Clin Pract 1995; 29:99–105.
<https://doi.org/10.1016/0168-8227(95)01117-X>
42. L, Radmila M, Jelena A, Dubravka D. Change in the iso-enzyme profiles of urinary N-acetyl-beta-D-glucosoaminidase in workers exposed to mercury. Toxicol Ind Health 2002; 18:207–14.
43. Z, Kuzniar J, Dlugosz A. Enzymatic markers of cyclosporine nephrotoxicity in patients after renal transplantation. Int Urol Nephrol 1999; 31: 727–34.
<https://doi.org/10.1023/A:1007181126577>
44. FT, Whiting PH, Thomson AW, Simpson JG. The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity. Biochem Pharmacol 1987; 36:699–703.
<https://doi.org/10.1016/0006-2952(87)90721-0>
45. H, Dimitriou E, Georgakis H et al. Iron overload and urinary lysosomal enzyme levles in beta-thalassaemia major. Eur J Pediatr 1997; 156:602–4.
<https://doi.org/10.1007/s004310050673>
46. H, Slowinska M. Concentration of metal, ceruloplasmin, metallothionein and the activity of N-acetyl-beta-D-glucosaminidase and gamma-glutamyltransferase in pregnant women who smoke and in those environmentally exposed to tobacco smoke and in their infants. Int J Occup Med Environ Health 1997; 10:187–202.
47. J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinaseassociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24:307–15.
<https://doi.org/10.1159/000078452>
48. H, Puri P. Urinary levels of N-acetyl-beta-D-glucosaminidase: a simple marker for predicting tubular damage in higher grades of vesicoureteric reflux. Eur Urol 1994; 25:135–7.
<https://doi.org/10.1159/000475267>
49. D, Greve D, Eggert P. Early tubular proteinuria and the development of nephritis in Henoch-Schonlein purpura. Pediatr Nephrol 2000; 15:85–9.
50. N, Yuksel B, Bakman M, Topaloglu AK, Ozer G. Urinary N-acetyl-beta- D-glucosaminidase activity in type I diabetes mellitus. Indian Pediatr 2003; 40:410–4.
51. JF, Mora C, Muros M, Maca M, Garca J. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study. Am J Kidney Dis 2003; 42:264–70.
<https://doi.org/10.1016/S0272-6386(03)00651-6>
52. M, Kawakatsu H, Komatsu H et al. Values for urinary beta-2–microglobulin and N-acetyl-betaD-glucosaminidase in normal healthy infants. Acta Paediatr Jpn 1998; 40:424–6.
<https://doi.org/10.1111/j.1442-200X.1998.tb01961.x>
53. DE, Thomas JK, Symonds WT et al. Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics. Ann Pharmacother 1997; 31:696–70.
<https://doi.org/10.1177/106002809703100605>
54. KM, Rudis MI, Rebuck JA et al. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Crit Care Med 2004; 32:1678–82.
<https://doi.org/10.1097/01.CCM.0000134832.11144.CB>
55. VA, Bekesi A, Toth A, Kovacs I, Balla G. Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy. Haematologia 1995; 26:151–7.
56. K, Konda R, Saka K, Ota S, Orikasa S. Eighteen cases of multicystic kidney: natural history and renal function of the contralateral kidney. Nippon Hinyokika Gakkai Zasshi 1996; 87:780–8.
57. I, Berki AC, Taylor SA, Price RG. Urea inhibition of urinary N-acetyl-β-Dglucosaminidase is mixed-type and is sensitive to changes of pH away from the optimum. Clin Chem 1993; 39:1918–9.
58. RG. The role of NAG (N-acetyl-β-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38:14–19.
59. RG. Measurement of N-acetyl-β-D-glucosaminidase and its isoenzymes in urine. methods and clinical applications. Eur J Clin Chem Clin Biochem 1992; 30:693–705.
60. E, Eber E, Erwa W, Zach MS. Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation. Arch Dis Child 1998; 78:540–3.
<https://doi.org/10.1136/adc.78.6.540>
<PubMed>
61. B, Tylicki L, Manitius J, Lysiak-Szydlowska W. Hypertensive nephropathy – an increasing clinical problem. Miner Electrolyte Metab 1999; 25:65–8.
<https://doi.org/10.1159/000057422>
62. MA, el-Habashy SA, Saeid OM, el-Tawil MM, Tawfik PH. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Pediatr Diabetes 2002; 3:37–41.
<https://doi.org/10.1034/j.1399-5448.2002.30107.x>
63. MC, Mateo-Caas J, Zamora-Madaria E. Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-beta-D-glucosaminidase in diabetes mellitus. An Med Interna 1995; 12:216–20.
64. S, Nishijo M, Ujjin P, Vanavanitkun Y, Baker JR, Moore MR. Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6–mediated coumarin metabolism in healthy human subjects. Toxicol Lett 2004; 148:187–97.
<https://doi.org/10.1016/j.toxlet.2003.10.028>
65. A, Sikora P, Semczuk M. N-acetyl-beta-D-glucosaminidase activity in women with preeclampsia. Ginekol Pol 2000; 71:141–5.
66. A, Sikora P, Biadun U, Semczuk M. Urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion in women with pregnancy complicated with hypertension. Ginekol Pol 2003; 74:1269–75.
67. P, Glatz S, Beck BB, Stapenhorst L, Zajaczkowska M, Hesse A. Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis. Pediatr Nephrol 2003; 18:996–9.
<https://doi.org/10.1007/s00467-003-1229-7>
68. S, Chládek J. Urinary N-acetyl-beta-D-glucosaminidase activity in healthy children. Nephrology 2004; 9:19–21.
<https://doi.org/10.1111/j.1440-1797.2003.00217.x>
69. AM, Addison GM, Price DA. Changes in the urinary excretion of creatinine, albumin, and N-acetyl-beta-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 1996; 155:596–602.
70. E, Feist D, Ruder H, Scharer K.Proteinuria and other renal functions in Wilson’s disease. Pediatr Nephrol 1997; 11:307–11.
71. FB, Chesney RW, Behrmann AT, Miller LA. Increased urinary excretion of renal N-acetyl-beta-glucosaminidase in hypercalciuria. Am J Dis Child 1985; 139:950–2.
72. C, Mancuso F, Lomurno G et al. N-acetyl-beta-D-glucosaminidase activity in urine of dental personnel. Clin Chim Acta 2004; 344:211–3.
<https://doi.org/10.1016/j.cccn.2004.02.028>
73. N, Kural N, Uslu S. N-acetyl-beta-D-glucosaminidase excretion in patients with unilateral renal agenesis or nephrectomy in childhood. Turk J Pediatr 1996; 38:485–90.
74. N, Kural N, Torun M. Renal function in children with hypercalciuria. Turk J Pediatr 1997; 39:335–9.
75. B, Zoch-Zwierz WM. Nephrotoxicity evaluation of cytostatic agents in children with acute lymphoblastic leukemia. Pediatr Pol 1995; 70:915–20.
76. PA, Smellie JM, Prescod N, Dalton RN, Chantler C. Differential excretion of urinary proteins in children with vesicoureteric reflux and reflux nephropathy. Pediatr Nephrol 1994; 8:21–5.
<https://doi.org/10.1007/BF00868252>
77. PA, Dalton RN, Hartley B, Haycock GB, Chantler C. Low molecular weight protein excretion in glomerular disease: a comparative analysis. Pediatr Nephrol 1997; 11:285–90.
<https://doi.org/10.1007/s004670050278>
78. M, Jakubowski M, Razniewska G, Halatek T, Gazewski A. The effects of environmental cadmium exposure on kidney function: the possible influence of age. Environ Res 2004; 95:143–150.
<https://doi.org/10.1016/j.envres.2003.10.003>
79. H, Hori C, Tsuchida S et al. Urinary N-acetyl-beta-D-glucosaminidase excretion in term and preterm neonates. J Paediatr Child Health 1994; 30:536–8.
<https://doi.org/10.1111/j.1440-1754.1994.tb00729.x>
80. SM, Pierce RJ, Price RG. Characterization of human N-acetyl-β-D-glucosaminidase isoenzymes as an indicator of tissue damage in disease. Clin Chim Acta 1980; 102:29–40.
<https://doi.org/10.1016/0009-8981(80)90430-1>
81. L, Manitius J, Lysiak-Szydlowska W, Rutkowski B. Tubular injury: the first symptom of hypertensive kidney involvement? Med Sci Monit 2003; 9:135–41.
82. M, Teranishi H, Aoshima K, Katoh T, Kasuya M, Inadera H. Reduction of erythrocyte catalase and superoxide dismutase activities in male inhabitants of a cadmium-polluted area in Jinzu river basin, Japan. Toxicol Lett 2004; 151: 451–7.
<https://doi.org/10.1016/j.toxlet.2004.03.009>
83. P, Peralta M, Carrizo L et al. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria. Pediatr Nephrol 2000; 15:252–8.
84. A, Greco R, Pascarella R, Matera V, Morgese G, Chiarelli F. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study. Epilepsia 2000; 41:1432–5.
<https://doi.org/10.1111/j.1528-1157.2000.tb00118.x>
85. A, Nagai J, Adachi Y et al. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists. J Control Release 2004; 95:423–33.
<https://doi.org/10.1016/j.jconrel.2003.12.005>
86. P, Szechcinski J. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol 2003; 55:631–7.
87. P, Wiela-Hojenska A, Glowska A et al. Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab. Clin Exp Rheumatol 2004; 22:469–72.
88. MA, Jones D, Noe HN. Urinary N-acetyl-beta-D-glucosaminidase as a screening technique for vesioureteral reflux. Urology 1994; 43:528–30.
<https://doi.org/10.1016/0090-4295(94)90248-8>
89. F, Summers J, Minutillo C, Hewitt I. Indices of renal tubular function in perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed 1997; 77:F57–60.
<https://doi.org/10.1136/fn.77.1.F57>
90. M, Stefaniak J, Sikora P et al. Urinary excretion of N-acetyl-beta- D-glucosaminidase and alpha1–microglobulin in children with proliferative blood diseases. Ann Univ Mariae Curie Sklodowska [Med] 2003; 58:348–53.
91. JH, Huang AX, Liu TL.Clinical study on treatment of childhood Henoch- Schonlein purpura nephritis with colquhounia root tablet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24:418–21.
92. G, Wiedemann G, Kallerhoff M, Zappel H, Weber MH, Ringert RH. Microproteinuria and enzymuria in fever and pyelonephritis in childhood. A prospective study of 180 children. Urologe A 1997; 36:68–76.
<https://doi.org/10.1007/s001200050069>
